CAR T Cells Encouraging for Diffuse Large B-Cell Lymphoma – Medscape
Medscape |
CAR T Cells Encouraging for Diffuse Large B-Cell Lymphoma
Medscape MADRID — Two investigational chimeric antigen receptor (CAR) modified T–cell therapies, both targeting CD19, have shown encouraging response rates in the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL), with adverse events … |
Cancer Network |
Role of Gut Microbiome in Metastatic Melanoma Patients on Immunotherapy
Cancer Network As part of our coverage of the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting, held June 2–6 in Chicago, we are joined by Jennifer Wargo, MD, an associate professor in the department of surgical oncology and genomic medicine at the … |
San Francisco Business Times |
Spark Therapeutics CEO talks drug pricing, gene therapy & his Philadelphia roots.
Philadelphia Business Journal “We generally pay for more diagnostic tests, procedures, visits and prescriptions. And I think [patients] should be paying for better outcomes and not for more health care.” Subscribe to get the full story. Already a subscriber? Sign in. Subscribe to … Cell, gene therapies are hot. But can this startup make them safer?San Francisco Business Times |
Science Daily |
Genetic engineering tool generates antioxidant-rich purple rice
Science Daily “Our research provides a high-efficiency vector system for stacking multiple genes for synthetic biology and makes it potentially feasible for engineering complex biosynthesis pathways in the endosperm of rice and other crop plants such as maize, wheat … |